
### [MONDO:0017021](http://purl.obolibrary.org/obo/MONDO_0017021)
**Label:** secondary interstitial lung disease specific to childhood associated with a connective tissue disease

**Subclasses:** [MONDO:0011429](http://purl.obolibrary.org/obo/MONDO_0011429) (juvenile rheumatoid arthritis), [MONDO:0008054](http://purl.obolibrary.org/obo/MONDO_0008054) (myositis), [MONDO:0018456](http://purl.obolibrary.org/obo/MONDO_0018456) (polyarticular juvenile idiopathic arthritis), [MONDO:0019432](http://purl.obolibrary.org/obo/MONDO_0019432) (rheumatoid factor-negative juvenile idiopathic arthritis), [MONDO:0019433](http://purl.obolibrary.org/obo/MONDO_0019433) (Oligoarticular juvenile idiopathic arthritis), [MONDO:0011577](http://purl.obolibrary.org/obo/MONDO_0011577) (myopathy, proximal, and ophthalmoplegia), [MONDO:0007827](http://purl.obolibrary.org/obo/MONDO_0007827) (inclusion body myositis), [MONDO:0011603](http://purl.obolibrary.org/obo/MONDO_0011603) (GNE myopathy), 

**Corr. equiv. classes:** [OMIM:160750](http://purl.obolibrary.org/obo/OMIM_160750), [OMIM:605637](http://purl.obolibrary.org/obo/OMIM_605637), [OMIM:604302](http://purl.obolibrary.org/obo/OMIM_604302), [OMIM:605820](http://purl.obolibrary.org/obo/OMIM_605820), [Orphanet:85408](http://www.orpha.net/ORDO/Orphanet_85408), [Orphanet:85414](http://www.orpha.net/ORDO/Orphanet_85414), [Orphanet:85410](http://www.orpha.net/ORDO/Orphanet_85410), [Orphanet:79091](http://www.orpha.net/ORDO/Orphanet_79091), [OMIM:147421](http://purl.obolibrary.org/obo/OMIM_147421), [OMIM:617158](http://purl.obolibrary.org/obo/OMIM_617158), [Orphanet:93672](http://www.orpha.net/ORDO/Orphanet_93672), [Orphanet:92](http://www.orpha.net/ORDO/Orphanet_92), [Orphanet:602](http://www.orpha.net/ORDO/Orphanet_602), [Orphanet:404580](http://www.orpha.net/ORDO/Orphanet_404580), [Orphanet:611](http://www.orpha.net/ORDO/Orphanet_611), 

**Class expressions from DL-Learner:**

- [HP:0002960](http://purl.obolibrary.org/obo/HP_0002960) (Autoimmunity) and [HP:0003565](http://purl.obolibrary.org/obo/HP_0003565) (Elevated erythrocyte sedimentation rate) and [HP:0025142](http://purl.obolibrary.org/obo/HP_0025142) (Constitutional symptom) 63.33%
- [HP:0002960](http://purl.obolibrary.org/obo/HP_0002960) (Autoimmunity) and [HP:0003565](http://purl.obolibrary.org/obo/HP_0003565) (Elevated erythrocyte sedimentation rate) and [HP:0012531](http://purl.obolibrary.org/obo/HP_0012531) (Pain) 63.33%
- [HP:0002960](http://purl.obolibrary.org/obo/HP_0002960) (Autoimmunity) and [HP:0003565](http://purl.obolibrary.org/obo/HP_0003565) (Elevated erythrocyte sedimentation rate) and [HP:0011842](http://purl.obolibrary.org/obo/HP_0011842) (Abnormality of skeletal morphology) 63.33%
- [HP:0002960](http://purl.obolibrary.org/obo/HP_0002960) (Autoimmunity) and [HP:0003565](http://purl.obolibrary.org/obo/HP_0003565) (Elevated erythrocyte sedimentation rate) and [HP:0011227](http://purl.obolibrary.org/obo/HP_0011227) (Elevated C-reactive protein level) 63.33%
- [HP:0002960](http://purl.obolibrary.org/obo/HP_0002960) (Autoimmunity) and [HP:0003565](http://purl.obolibrary.org/obo/HP_0003565) (Elevated erythrocyte sedimentation rate) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) 63.33%
- [HP:0002960](http://purl.obolibrary.org/obo/HP_0002960) (Autoimmunity) and [HP:0003565](http://purl.obolibrary.org/obo/HP_0003565) (Elevated erythrocyte sedimentation rate) and [HP:0010876](http://purl.obolibrary.org/obo/HP_0010876) (Abnormality of circulating protein level) 63.33%
- [HP:0002829](http://purl.obolibrary.org/obo/HP_0002829) (Arthralgia) and [HP:0002960](http://purl.obolibrary.org/obo/HP_0002960) (Autoimmunity) and [HP:0003565](http://purl.obolibrary.org/obo/HP_0003565) (Elevated erythrocyte sedimentation rate) 63.33%
- [HP:0001369](http://purl.obolibrary.org/obo/HP_0001369) (Arthritis) and [HP:0003565](http://purl.obolibrary.org/obo/HP_0003565) (Elevated erythrocyte sedimentation rate) and [HP:0011227](http://purl.obolibrary.org/obo/HP_0011227) (Elevated C-reactive protein level) 63.33%
- [HP:0001369](http://purl.obolibrary.org/obo/HP_0001369) (Arthritis) and [HP:0003565](http://purl.obolibrary.org/obo/HP_0003565) (Elevated erythrocyte sedimentation rate) and [HP:0010876](http://purl.obolibrary.org/obo/HP_0010876) (Abnormality of circulating protein level) 63.33%
- [HP:0001369](http://purl.obolibrary.org/obo/HP_0001369) (Arthritis) and [HP:0002960](http://purl.obolibrary.org/obo/HP_0002960) (Autoimmunity) and [HP:0003565](http://purl.obolibrary.org/obo/HP_0003565) (Elevated erythrocyte sedimentation rate) 63.33%
- [HP:0001367](http://purl.obolibrary.org/obo/HP_0001367) (Abnormal joint morphology) and [HP:0002960](http://purl.obolibrary.org/obo/HP_0002960) (Autoimmunity) and [HP:0003565](http://purl.obolibrary.org/obo/HP_0003565) (Elevated erythrocyte sedimentation rate) 63.33%
- [HP:0000969](http://purl.obolibrary.org/obo/HP_0000969) (Edema) and [HP:0002960](http://purl.obolibrary.org/obo/HP_0002960) (Autoimmunity) and [HP:0003565](http://purl.obolibrary.org/obo/HP_0003565) (Elevated erythrocyte sedimentation rate) 63.33%
- [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) and [HP:0002960](http://purl.obolibrary.org/obo/HP_0002960) (Autoimmunity) and [HP:0003565](http://purl.obolibrary.org/obo/HP_0003565) (Elevated erythrocyte sedimentation rate) 63.33%
- [HP:0002960](http://purl.obolibrary.org/obo/HP_0002960) (Autoimmunity) and [HP:0003565](http://purl.obolibrary.org/obo/HP_0003565) (Elevated erythrocyte sedimentation rate) and [HP:0011842](http://purl.obolibrary.org/obo/HP_0011842) (Abnormality of skeletal morphology) and [HP:0025142](http://purl.obolibrary.org/obo/HP_0025142) (Constitutional symptom) 63.33%
- [HP:0002960](http://purl.obolibrary.org/obo/HP_0002960) (Autoimmunity) and [HP:0003565](http://purl.obolibrary.org/obo/HP_0003565) (Elevated erythrocyte sedimentation rate) and [HP:0011842](http://purl.obolibrary.org/obo/HP_0011842) (Abnormality of skeletal morphology) and [HP:0012531](http://purl.obolibrary.org/obo/HP_0012531) (Pain) 63.33%


